Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | Q9HBH1 | 7/20 | 0.80 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4956865 | 1.00 | PDF (0.80) | ||
| SCHEMBL4956500 | 1.00 | PDF (0.80) | ||
| SCHEMBL13761273 | 1.00 | PDF (0.80) | ||
| SCHEMBL4956863 | 1.00 | PDF (0.80) | ||
| SCHEMBL14523357 | 0.96 | PDF (0.74) | ||
| SCHEMBL14282147 | 0.96 | PDF (0.74) | ||
| SCHEMBL14282153 | 0.95 | PDF (0.73) | ||
| SCHEMBL14282154 | 0.95 | PDF (0.73) | ||
| SCHEMBL14282155 | 0.95 | PDF (0.73) | ||
| SCHEMBL14282149 | 0.94 | PDF (0.76) |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203631-A1 | PEPTIDE DEFORMYLASE INHIBITORS AS NOVEL ANTIBIOTICS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-08-13 | — | — | US | disclosed |
| US-7538085-B2 | Macrocyclic peptide antibiotics; drug resistant, drug sensitive bacterial infections | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-05-26 | — | — | US | disclosed |
| US-7323448-B2 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2008-01-29 | — | — | US | disclosed |
| US-7323448-B2 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2008-01-29 | — | — | US | disclosed |
| US-20070259812-A1 | Peptide deformylase inhibitors as novel antibiotics | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION | 2007-11-08 | — | — | US | disclosed |
| US-20070259812-A1 | Peptide deformylase inhibitors as novel antibiotics | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION | 2007-11-08 | — | — | US | disclosed |
| US-20070135353-A1 | Crystalline n-formyl hydroxylamine compounds | NOVARTIS AG (CH) | 2007-06-14 | — | — | US | disclosed |
| US-7208595-B2 | Peptide deformylase inhibitors as novel antibiotics | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2007-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135353-A1 | Crystalline n-formyl hydroxylamine compounds | HNMT, FPR1, NAT1 | PDF 302/4885 |
| US-20090203631-A1 | PEPTIDE DEFORMYLASE INHIBITORS AS NOVEL ANTIBIOTICS | PDF, PADI3, PADI6 | PDF 1/4885 |
| US-20070259812-A1 | Peptide deformylase inhibitors as novel antibiotics | PDF, PADI3, PADI6 | PDF 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.